Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Efficacy of Mesenchymal Stem Cell Therapy on Glucose Levels in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Publisher Pubmed



Ranjbaran H1 ; Mohammadi Jobani B2 ; Amirfakhrian E3 ; Alizadehnavaei R4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunogenetics Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
  2. 2. Pediatric Urology Research Center, Department of Pediatric Urology, Children’s Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
  4. 4. Gastrointestinal Cancer Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Source: Journal of Diabetes Investigation Published:2021


Abstract

Aims/Introduction: In recent years, mesenchymal cellular therapies have received much attention in the treatment of diabetes. In this meta-analysis, we aimed to evaluate the efficacy of mesenchymal stem cell therapy in type 2 diabetes mellitus patients. Materials and Methods: A comprehensive literature search was carried out using PubMed, Scopus, Web of Science and Central databases. A total of 1,721 articles were identified, from which nine full-text clinical trials were qualified to enter the current meta-analysis. The assessment groups included patients with type 2 diabetes, and levels of C-peptide, glycosylated hemoglobin and insulin dose were analyzed before and after mesenchymal stem cell infusion. Data analysis was carried out in Stata version 11, and the Jadad Score Scale was applied for quality assessment. Results: Changes in levels of C-peptide after mesenchymal stem cell therapy were: standardized mean difference 0.20, 95% confidence interval −0.61 to 1.00, glycosylated hemoglobin levels were: standardized mean difference −1.45, 95% confidence interval −2.10 to −0.79 and insulin dose were: standardized mean difference −1.40, 95% confidence interval −2.88 to 0.09. Conclusions: This meta-analysis of prospective studies showed associations between mesenchymal stem cell therapy and control of glucose level in patients with type 2 diabetes. © 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
Related Docs
View other Related Docs
1. Stem Cell Therapy for Patients With Diabetes: A Systematic Review and Meta-Analysis of Metabolomics-Based Risks and Benefits, Stem Cell Investigation (2018)
2. Investigating the Safety and Efficacy of Hematopoietic and Mesenchymal Stem Cell Transplantation for Treatment of T1dm: A Systematic Review and Meta-Analysis, Systematic Reviews (2022)
3. Safety and Efficacy of Hematopoietic and Mesanchymal Stem Cell Therapy for Treatment of T1dm: A Systematic Review and Meta-Analysis Protocol, Systematic Reviews (2018)
4. Shining the Light on Clinical Application of Mesenchymal Stem Cell Therapy in Autoimmune Diseases, Stem Cell Research and Therapy (2022)
5. Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type-1 Diabetes Patients: A Phase I/Ii Randomized Placebo-Controlled Clinical Trial, Stem Cell Research and Therapy (2022)
6. Bone Marrow Mesenchymal Stromal Cells for Diabetes Therapy: Touch, Fuse, and Fix?, Stem Cell Research and Therapy (2022)
7. Photobiomodulation Therapy Compensate the Impairments of Diabetic Bone Marrow Mesenchymal Stem Cells, Lasers in Medical Science (2020)
8. Mesenchymal Stem Cells: Rising Concerns Over Their Application in Treatment of Type One Diabetes Mellitus, Journal of Diabetes Research (2015)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (3)
Arya Sotoudeh (1)
Other Related Docs
9. Challenges in Mesenchymal Stromal Cell-Based Therapies, Current Stem Cell Research and Therapy (2023)